The cumulative burden of diabetes worldwide has been ever increasing over recent decades. New drugs are being developed at a rapid pace, and the last few years have seen several new classes of compounds for the treatment of diabetes. Likewise, stem cell therapy holds a huge potential for the treatment of patients with diabetes.
Extensive research on the potency of human embryonic stem cells to differentiate into islet cells has defined the developing stages and factors of transcription involved in this process. This exclusive KOL Interview, explains the promise that stem cell therapy holds for the treatment of diabetes patients.
